rlt, gil, roulette, sty, arg
ligand for Egf receptor - inhibitor of Egfr activation - controls formation of embryonic brain neuroblasts by regulating neuroectodermal progenitor cells
Please see the JBrowse view of Dmel\aos for information on other features
To submit a correction to a gene model please use the Contact FlyBase form
AlphaFold produces a per-residue confidence score (pLDDT) between 0 and 100. Some regions with low pLDDT may be unstructured in isolation.
Gene model reviewed during 5.45
4.5 (northern blot)
There is only one protein coding transcript and one polypeptide associated with this gene
444 (aa)
444 (aa); 50 (kD predicted)
Interacts with spi.
The three two-fingered repeats tightly encircle spi, providing the basis for it's sequestration. The first repeat harbors a 120 AA insert specific to drosophilidae.
Click to get a list of regulatory features (enhancers, TFBS, etc.) and gene disruptions (point mutations, indels, etc.) within or overlapping Dmel\aos using the Feature Mapper tool.
The testis specificity index was calculated from modENCODE tissue expression data by Vedelek et al., 2018 to indicate the degree of testis enrichment compared to other tissues. Scores range from -2.52 (underrepresented) to 5.2 (very high testis bias).
Comment: anlage in statu nascendi
Comment: anlage in statu nascendi
Comment: reported as procephalic ectoderm anlage in statu nascendi
Comment: reported as procephalic ectoderm anlage in statu nascendi
Comment: reported as procephalic ectoderm anlage in statu nascendi
Comment: reported as procephalic ectoderm anlage
Comment: reported as procephalic ectoderm anlage
Comment: reported as procephalic ectoderm anlage
Comment: reported as procephalic ectoderm anlage
Comment: reported as procephalic ectoderm primordium
Comment: reported as procephalic ectoderm primordium
Comment: reported as procephalic ectoderm primordium
Comment: reported as procephalic ectoderm primordium
Comment: reported as procephalic ectoderm primordium
Comment: reported as procephalic ectoderm primordium
Comment: AMG
Expression assayed at stages 9, 11, 13, and 17. Expression may be continuous between assayed stages in some tissues.
Expression pattern inferred from unspecified enhancer trap line.
Expression is observed in the anterior midline glial cells.
At cellularization, aos transcript is expressed in a pair of dorsal bands just anterior and posterior to the presumptive cephalic furrow, as well as in a dorsal terminal domain at bothe the anterior and posterior termini of the embryo.
aos is expressed in a complex anddynamic pattern in embryos. It is first observed in the cellularblastoderm in dorsal regions at the anterior and posterior ends and in thedorsal ectoderm anlage, in a pair-rule pattern. At stage 9, expressionoccurs in two rows of ectodermal cells bordering the mesectoderm. As themesectoderm invaginates, the rows meet and aos expression occurs in theentire ventral ectoderm. In germ band extended embryos, additionalexpression is seen in the head region and in segmentally repeated groupsof ectodermal cells. aos is expressed in dorsal and lateral epidermalcells located at the segment boundary and in all ventral epidermal cellsuntil stage 16. As the germ band retracts, aos is expressed in themidline glial cells. In third instar larvae, aos is expressed behind themorphogenetic furrow. See the associated enhancer trap pattern forEcollacZargos-W11.
The expression pattern of aos isidentical to that of the enhancer trap line EcollacZargos-A254.
Comment: mesonotum
JBrowse - Visual display of RNA-Seq signals
View Dmel\aos in JBrowse3-44
3-39.0
Please Note FlyBase no longer curates genomic clone accessions so this list may not be complete
Please Note This section lists cDNAs and ESTs that fall within the genomic extent of the gene model, which may include cDNAs and ESTs of genes within introns, or of overlapping genes. Please see JBrowse for alignment of the cDNAs and ESTs to the gene model.
For each fully sequenced cDNA the DGRC maintains various forms of the cDNA (e.g tagged or untagged) in several different host vectors for subsequent cloning and expression in Drosophila and Drosophila cell lines.
argos is not required for patterning of the dorsal anterior follicular epithelium.
ChEST reveals this is a target of Mef2.
argos mediate the number of bracts per mechanosensory bristle in the leg by lateral inhibition.
argos exerts its inhibitory function through dual mechanisms: by blocking both the receptor dimerisation and the binding of activating ligand to the receptor.
argos has a role in dorsal-ventral and anterior-posterior patterning in the egg.
The extended B loop of the atypical argos EGF domain is necessary for its function.
Shows no genetic interaction with sdk.
In vivo culture of mutant discs from genotypes that are normally embryonic lethal demonstrates argos has no role in wing disc growth.
argos is a negative regulator of midline glia cell survival in embryos.
argos acts negatively to restrict the number of chordotonal (Ch) organs but not external sensory (Es) organs.
A null mutation causes an increase in chordotonal (Ch) organs in thoracic and abdominal segments. Overexpression causes a reduction in number of Ch organs. The phenotype of a argos null mutant is not observed in a rho mutant background, indicating that rho acts epistatically to argos to regulate the correct number of Ch organs in the embryonic PNS.
The argos gene product is a negative regulator of signal transduction that acts upstream of the Ras/MAPK cascade.
argos is required for projection of photoreceptor axons during optic lobe development.
Clonal analysis demonstrates argos is not required in the photoreceptor axons for correct axonal pathfinding.
The argos product plays an essential role in optic lobe development.
argos mutants act on the development of lamina cells preventing the correct differentiation of the target region of photoreceptor axons and therefore leading to an axon guidance phenotype.
The argos locus was identified on the basis of the rough eye phenotype of its mutants.
Overexpression of argos causes the loss of cells in the developing eye.
argos functions to regulate cell fate decisions as a negative signal in the developing eye and wing discs.
argos gene product may be a new type of secreted signalling molecule involved in the process of axon pathfinding and cell determination in the visual system.
argos may act as an inhibitory signal for cellular differentiation in the developing eye and wing.
Clonal analysis indicates that argos acts nonautonomously.
argos has important functions in cell determination in the eye, in photoreceptor axon pathfinding and in optic lobe development.
Source for merge of: argos rlt
"rlt" is a regulatory allele of "argos".
Source for identity of: argos rlt
Source for identity of: aos argos